N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review
Pediatric oncology is a critical area where the more efficient development of new treatments is urgently needed. The speed of approval of new drugs is still limited by regulatory requirements and a lack of innovative designs appropriate for trials in children. Childhood cancers meet the criteria of...
Enregistré dans:
Auteurs principaux: | Michal Kyr, Adam Svobodnik, Radka Stepanova, Renata Hejnova |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e362beda12c3412aac9b32d23e3902c8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Cost of Oncology Medicines
par: Zlatareva A., et autres
Publié: (2017) -
Pediatric Oncology Palliative Care Programs in Central America: Pathways to Success
par: Wendy Cristhyna Gómez García, et autres
Publié: (2021) - Clinical medicine reviews in oncology
-
Precision oncology- the future of personalized cancer medicine?
par: Ann M. Bode, et autres
Publié: (2017) - European Journal of Oncological Medicine